GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+7.17%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$970M
AUM Growth
+$970M
(+6.6%)
Cap. Flow
+$2.03M
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
28.54%
Holding
185
New
9
Increased
36
Reduced
73
Closed
2
Top Buys
| 1 |
Chubb
CB
|
$4.24M |
| 2 |
Amdocs
DOX
|
$1.89M |
| 3 |
WPP
WPP
|
$1.77M |
| 4 |
Trimble
TRMB
|
$1.66M |
| 5 |
PPG Industries
PPG
|
$1.44M |
Top Sells
| 1 |
COL
Rockwell Collins
COL
|
$4.4M |
| 2 |
AT&T
T
|
$2.6M |
| 3 |
Dentsply Sirona
XRAY
|
$1.98M |
| 4 |
Microsoft
MSFT
|
$1.08M |
| 5 |
Vodafone
VOD
|
$849K |
Sector Composition
| 1 | Technology | 24.05% |
| 2 | Healthcare | 17.46% |
| 3 | Financials | 11.19% |
| 4 | Industrials | 9.86% |
| 5 | Consumer Staples | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Boeing
BA
$177B
| $901K | 0.09% |
2,423
| – | – |
|
102
Fastenal
FAST
$57B
| $898K | 0.09% |
15,485
-150
| -1% | -$8.7K |
|
103
Intuitive Surgical
ISRG
$170B
| $887K | 0.09% |
1,546
| – | – |
|
|
SGEN
104
DELISTED
Seagen Inc. Common Stock
SGEN
| $862K | 0.09% |
11,171
+95
| +0.9% | +$7.33K |
|
105
Charles Schwab
SCHW
$174B
| $791K | 0.08% |
16,092
-1,000
| -6% | -$49.2K |
|
|
NBL
106
DELISTED
Noble Energy, Inc.
NBL
| $772K | 0.08% |
24,749
| – | – |
|
|
RDS.A
107
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $759K | 0.08% |
11,139
| – | – |
|
108
Vanguard Large-Cap ETF
VV
$44.5B
| $732K | 0.08% |
+5,485
| New | +$732K |
|
109
Visa
V
$683B
| $719K | 0.07% |
4,790
-436
| -8% | -$65.4K |
|
110
Ionis Pharmaceuticals
IONS
$6.8B
| $700K | 0.07% |
13,579
+110
| +0.8% | +$5.67K |
|
111
Altria Group
MO
$113B
| $697K | 0.07% |
11,554
| – | – |
|
112
Eli Lilly
LLY
$657B
| $690K | 0.07% |
6,425
| – | – |
|
|
CHX
113
DELISTED
ChampionX
CHX
| $684K | 0.07% |
15,708
-900
| -5% | -$39.2K |
|
114
CSX Corp
CSX
$60.6B
| $681K | 0.07% |
9,200
| – | – |
|
115
Amazon
AMZN
$2.44T
| $671K | 0.07% |
335
| – | – |
|
116
AbbVie
ABBV
$372B
| $658K | 0.07% |
6,961
-1,093
| -14% | -$103K |
|
117
BioMarin Pharmaceuticals
BMRN
$11.2B
| $646K | 0.07% |
6,662
+70
| +1% | +$6.79K |
|
118
SPDR Gold Trust
GLD
$107B
| $646K | 0.07% |
5,727
| – | – |
|
119
H.B. Fuller
FUL
$3.29B
| $625K | 0.06% |
12,094
| – | – |
|
120
Schlumberger
SLB
$55B
| $621K | 0.06% |
10,198
| – | – |
|
121
Fiserv
FI
$75.1B
| $581K | 0.06% |
7,048
| – | – |
|
122
Jacobs Solutions
J
$17.5B
| $578K | 0.06% |
7,555
| – | – |
|
123
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $573K | 0.06% |
11,000
| – | – |
|
124
Incyte
INCY
$16.5B
| $550K | 0.06% |
7,968
+75
| +1% | +$5.18K |
|
|
ALXN
125
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $539K | 0.06% |
3,880
+35
| +0.9% | +$4.86K |
|